Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Clinical trial NCT01922102 · COMPLETED
Trial details
- NCT number
- NCT01922102
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-11
- Primary completion
- 2016-09-14
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.